RenovoRx, Inc. (RNXT) Reports In-Line Q3 EPS

RenovoRx, Inc. (NASDAQ: RNXT) reported Q3 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $397.07 thousand.

For earnings history and earnings-related data on RenovoRx, Inc. (RNXT) click here.

You May Also Be Interested In

• Chevron signed an agreement with Iraq's Basra Oil Company to advance commercial negotiations for West Qurna 2
• Penguin Solutions closes $750M convertible notes offering due 2031
• DWS Municipal Income Trust sets November 2026 liquidation timeline